# \[e-drug\] Preliminary announcement training course **URL:** \ **Category:** e-drug\ **Created:** [May 15, 2003, 9:57pm UTC](https://talk.edrugplus.org/t/e-drug-preliminary-announcement-training-course/16776 "2003-05-15T21:57:15Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![Perla\_Mordujovich](https://avatars.discourse-cdn.com/v4/letter/p/cc9497/32.png) [@Perla\_Mordujovich](https://talk.edrugplus.org/u/Perla_Mordujovich)\ **Post date:** [May 15, 2003, 9:57pm UTC](https://talk.edrugplus.org/t/e-drug-preliminary-announcement-training-course/16776/1 "2003-05-15T21:57:15Z")
E-drug: Preliminary announcement training course ------------------------------------------------------------------------- PRELIMINARY ANNOUNCEMENT Fifth Latin American Course on Problem-based Pharmacotherapy teaching (spanish language) 31 August -12 september 2003, La Plata, Argentina. ORGANISED BY: Centro Universitario de Farmacologma (CUFAR) Facultad de Medicina, Universidad Nacional de La Plata (Argentina); EDM/PAR ,World Health Organization, Geneva, Switzerland; Pan-American Health Organization, Buenos Aires/Argentine - Washington/USA TO WHOM IS DIRECTED 1 - Multipliers to be trained to replicate this course 2 - Teachers of Pharmacotherapy, Clinical Medicine, Pediatrics, Gerontology working in undergraduate or postgraduate settings, medical schools, teaching hospitals, etc. COURSE OBJECTIVES GENERAL OBJECTIVE \* The main aim of this course is to provide knowledge and practical experience on a problem-based approach for pharmacotherapy teaching. SPECIFIC OBJECTIVES At the end of the course, participants are expected to have: \* Obtained and experienced a methodology to facilitate the students to develop criteria to choose and apply drug therapy and/or appropriate treatment to solve health problems. \* Obtained appropriate knowledge on problem-based method of learning/teaching medicine and pharmacotherapy. \* Obtained and experienced knowledge and necessary skills to train teachers to develop abilities to be facilitators in the framework of ABP. \* Obtained the knowledge and necessary skills to plan, develop , implement and assess a problem-based pharmacotherapy course, in their own medical school or educational institution. \* Acquired critical appraisal in the use of sources of information about drugs and treatments. METHODOLOGY The course is based on the methodology developed by the University of Groningen, Faculty of Medical Sciences, Department of Clinical Pharmacology (Netherlands). The underlying principles of the model are from the WHO Guide to Good Prescribing, WHO Geneva, Switzerland, 1994. This course was succesfully introduced in Europe, Africa and Asia, and since 1999 has been developed in America, "Catedra de Farmacologma", Facultad de Ciencias Medicas , Universidad Nacional de La Plata, La Plata, Argentina, in spanish. FACULTY The Course will be facilitated by an academic staff of the "Universidad Nacional de La Plata" with the contribution of national and international guests. Also will be present representatives from the World Health Organization, Geneva, Switzerland and/or from the Pan-American Health Organization, Buenos Aires/Argentina - Washington/USA. NUMBERS To achieve the maximum opportunities for small group work and interactive learning the course will be limited to 30 participants. LANGUAGE The working language of the course will be spanish. For more information, and requests for registration, please contact: Dra. Perla M. de Buschiazzo Centro Universitario de Farmacologma (CUFAR) Facultad de Ciencias Medicas Universidad Nacional de La Plata Calle 60 y 120- 3er piso La Plata.1900. ARGENTINA Tel/fax: 54 (221) 421-6932 Fax : 54 (221) 423-6710 E-mail: pmordujo@netverk.com.ar pmordujo@atlas.med.unlp.edu.ar -- To send a message to E-Drug, write to: e-drug@healthnet.org To subscribe or unsubscribe, write to: majordomo@healthnet.org in the body of the message type: subscribe e-drug OR unsubscribe e-drug To contact a person, send a message to: e-drug-help@healthnet.org Information and archives: [http://www.essentialdrugs.org/edrug](http://www.essentialdrugs.org/edrug)